MAHON, FX. Intergroupe Francais des Leucemies Myeloides Chroniques. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years : the prospective, multicentre Stop Imatinib (STIM) trial. Lancet Oncol. 2010, 11, 1029-1035
GRAHAM, SM. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood. 2002, 99, 319-325
STUART, SA. The CML stem cell : evolution of the progenitor. Cell Cycle. 2009, 8, 1338-1343